Skip to main content
. Author manuscript; available in PMC: 2021 Mar 19.
Published in final edited form as: J Am Geriatr Soc. 2018 Oct 11;67(1):74–80. doi: 10.1111/jgs.15603

Table 3.

Central Nervous System (CNS) Standardized Daily Dose Within 6 Days Before Outcome According to Medication Class

CNS Medication Class
Controls, n = 1,264
Cases, n = 316
P-Value1
Mean±Standard Deviation, Median (Interquartile Range)
Antidepressant (serotonin norepinephrine reuptake inhibitor, selective serotonin reuptake inhibitor, tricyclic antidepressant) 0.88 ± 1.51, 0 (0–1.50) 0.81 ± 1.36, 0 (0–1.58) .46
Antiepileptic 0.25 ± 0.60, 0 (0–0) 0.24 ± 0.56, 0 (0–0) .78
Antipsychotic 0.74 ± 2.59, 0 (0–0) 1.02 ± 4.62, 0 (0–0.25) .16
Benzodiazepine receptor agonist 0.36 ± 1.47, 0 (0–0) 0.34 ± 1.07, 0 (0–0) .83
Opioids receptor agonists 1.08 ± 3.22, 0 (0–0.67) 1.99 ± 5.13, 0.11 (0–2.0) <.001
All CNS medications 3.32 ± 4.97, 1.91 (0.25–4.01) 4.41 ± 7.25, 2.50 (0.50–5.75) .002
1

Conditional logistic regression model